1) vasoactive mediator
血管活性介质
1.
Clinical observation on effects of Shengmai injection(生脉注射液) on plasma vasoactive mediators in patients with systemic inflammatory response syndrome;
生脉注射液对全身炎症反应综合征患者血浆血管活性介质影响的临床观察
2) Vasoactive substance
血管活性物质
1.
Study on the role of vasoactive substances in the pathogenesis of hypertension in patients with sleep apnea syndrome;
血管活性物质在睡眠呼吸暂停综合征合并高血压中作用的研究
2.
Effect of sleep-apnea syndrome on vasoactive substances;
睡眠呼吸暂停低通气综合征患者血管活性物质的变化
3.
The effects of nCPAP on blood pressure and vasoactive substances in patients with SAS;
nCPAP治疗SAS的效果及对血压和血管活性物质的影响
3) Vasoactive substances
血管活性物质
1.
Effects of soy oligosaccharides and peptides on vasoactive substances and hemorheology in hyperlipidemia rats;
大豆低聚糖和低聚肽对高脂血症大鼠血管活性物质和血液流变学的影响
2.
Changes of vasoactive substances originated endothelium on patients with unstable angina pectoris treated by low dose of urokinase;
不稳定型心绞痛患者应用小剂量尿激酶前后内皮源性血管活性物质的变化(英文)
3.
Objective To observe the influence of preventive treatment by regulating the function of liver and kidney and removing sputum and blood stasis therapy (RR-Therapy) on the development of SHR hypertension and several vasoactive substances.
目的 探讨调肝肾、祛痰瘀治法方药提前干预对自发性高血压大鼠(SHR)的高血压发展以及对多种血管活性物质的作用。
4) vaso-active substance
血管活性物质
1.
Vaso-active substances including nitric oxide(NO) and endothelin(ET) were measured.
方法 :选择无心血管疾病的SAS患者和正常对照组各 30例进行多导睡眠图 (PSG)、2 4h动态血压 (ABPM )及血管活性物质一氧化氮 (NO)和内皮素 (ET)的监测。
2.
The methods of treating EH with Chinese medicine are mainly from following links:to change hemodynamics and hemorheology mechanisms;to affect RAS;to adjust vaso-active substance;to control the function of cell membranes\' calcium channel and to resist IR.
中医药治疗高血压的途径主要从一下几个环节入手:改变血流动力学和血液流变学机制、对肾素—血管紧张素系统的影响、调节血管活性物质、调控细胞膜钙通道的机能以及抑制胰岛素抵抗等。
6) Vasoconstrictor
[英][,væsəukən'striktə] [美][,væsokən'strɪktɚ]
缩血管活性物质
1.
Object To find the role of ROS in increased paracrine of hypertrophic cardiomyocytes induced by the vasoconstrictors including ET-1 ,AngⅡ.
目的:探讨氧活性产物(reactive oxygen species,ROS)在血管紧张素Ⅱ(AngⅡ),内皮素-1(ET-1)等缩血管活性物质在致心肌细胞肥大时同时促进心肌细胞分泌内皮素中所起的作用。
补充资料：肠血管活性多肽
肠血管活性多肽
又称"血管活性肠肽"。 VIP最初从猪肠中分离获得，现已能人工合成。它的突出作用为强烈的血管扩张。可有正性心肌肌力作用，但可引起血压下降。在胃肠道其作用很广泛，可抑制胃酸、胃蛋白酶分泌，使胃肌松弛；激活肠粘膜的腺苷酸环化酶而促进肠液分泌及肠道收缩；促进胰分泌HCOs-及水；还能加强胰岛素及高血糖素分泌，促进糖原及脂肪分解。但目前对它的本质的了解不清楚，有待研究。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条